SAN DIEGO--(BUSINESS WIRE)--Abintus Bio, Inc. (Abintus), a biotechnology company pioneering first-in-class, in vivo genetic medicines that engineer cells directly inside the body, today announced that ...
Northeastern University researchers used an original machine learning tool to predict how genetic mutations cause a rare ...
As Earth's climate warms and changes, sustainable agricultural practices are critical for feeding a rapidly growing population. Can we genetically engineer crops to adapt to drought and other effects ...
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
Astromech represents the strategic convergence of synthetic biology expertise with artificial intelligence development capabilities through the partnership of Ben Lamm and George Church. The venture ...
The human genome is driving healthcare innovation, and the biopharmaceutical industry is increasingly focusing research and development centered on understanding the role of genetics in health and ...
GATC brought together a broad coalition of researchers and executives in cell and gene therapy, gene editing, drug discovery and AI as well as patients and advocates.
The inaugural Genetic Agency Technology Conference (GATC) gathered a group of researchers and entrepreneurs to discuss the vision for AI-based genetic medicine.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results